ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund

March 21, 1997

Love, Avon Foundations Recruit Women For Research.

October 3, 2008

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

May 3, 2002

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

NIH Introduces “Modular” Gran Application And Awards

February 26, 1999